°£Æí°áÁ¦, ½Å¿ëÄ«µå û±¸ÇÒÀÎ
ÀÎÅÍÆÄÅ© ·Ôµ¥Ä«µå 5% (38,000¿ø)
(ÃÖ´ëÇÒÀÎ 10¸¸¿ø / Àü¿ù½ÇÀû 40¸¸¿ø)
ºÏÇǴϾð ·Ôµ¥Ä«µå 30% (28,000¿ø)
(ÃÖ´ëÇÒÀÎ 3¸¸¿ø / 3¸¸¿ø ÀÌ»ó °áÁ¦)
NH¼îÇÎ&ÀÎÅÍÆÄÅ©Ä«µå 20% (32,000¿ø)
(ÃÖ´ëÇÒÀÎ 4¸¸¿ø / 2¸¸¿ø ÀÌ»ó °áÁ¦)
Close

»ï¼º³»°ú¸Å´º¾ó : Handbook of Internal Medicine 8th

¼Òµæ°øÁ¦

2013³â 9¿ù 9ÀÏ ÀÌÈÄ ´©Àû¼öÄ¡ÀÔ´Ï´Ù.

ÆǸÅÁö¼ö 26
?
ÆǸÅÁö¼ö¶õ?
»çÀÌÆ®ÀÇ ÆǸŷ®¿¡ ±â¹ÝÇÏ¿© ÆǸŷ® ÃßÀ̸¦ ¹Ý¿µÇÑ ÀÎÅÍÆÄÅ© µµ¼­¿¡¼­ÀÇ µ¶¸³ÀûÀÎ ÆǸŠÁö¼öÀÔ´Ï´Ù. ÇöÀç °¡Àå Àß Æȸ®´Â »óÇ°¿¡ °¡ÁßÄ¡¸¦ µÎ¾ú±â ¶§¹®¿¡ ½ÇÁ¦ ´©Àû ÆǸŷ®°ú´Â ´Ù¼Ò Â÷ÀÌ°¡ ÀÖÀ» ¼ö ÀÖ½À´Ï´Ù. ÆǸŷ® ¿Ü¿¡µµ ´Ù¾çÇÑ °¡ÁßÄ¡·Î ±¸¼ºµÇ¾î ÃÖ±ÙÀÇ À̽´µµ¼­ È®Àνà À¯¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇØ´ç Áö¼ö´Â ¸ÅÀÏ °»½ÅµË´Ï´Ù.
Close
°øÀ¯Çϱâ
Á¤°¡

40,000¿ø

  • 40,000¿ø

    1,200P (3%Àû¸³)

ÇÒÀÎÇýÅÃ
Àû¸³ÇýÅÃ
  • S-Point Àû¸³Àº ¸¶ÀÌÆäÀÌÁö¿¡¼­ Á÷Á¢ ±¸¸ÅÈ®Á¤ÇϽŠ°æ¿ì¸¸ Àû¸³ µË´Ï´Ù.
Ãß°¡ÇýÅÃ
¹è¼ÛÁ¤º¸
  • 5/8(¼ö) À̳» ¹ß¼Û ¿¹Á¤  (¼­¿ï½Ã °­³²±¸ »ï¼º·Î 512)
  • ¹«·á¹è¼Û
ÁÖ¹®¼ö·®
°¨¼Ò Áõ°¡
  • À̺¥Æ®/±âȹÀü

  • ¿¬°üµµ¼­

  • »óÇ°±Ç

AD

Ã¥¼Ò°³

»ï¼º³»°ú¸Å´º¾óÀº ³»°ú ÁÖÄ¡ÀǷμ­ ¹Ýµå½Ã ¾Ë¾Æ¾ß ÇÏ´Â ÃֽŠÁø·áÁöħ, °¡À̵å¶óÀÎÀÌ ºüÁü¾øÀÌ ¼ö·ÏµÈ Æ÷ÄÏ ¸Å´º¾óÀÌ´Ù.
ù°, º´µ¿°ú ÀÀ±Þ½Ç, ÁßȯÀڽǿ¡¼­ ³»°ú ¼ö·ÃÀǵéÀÌ ÈçÇÏ°Ô Á¢ÇÏ´Â ÁúȯÀ» Áß½ÉÀ¸·Î ÀÌ¿¡ ´ëÇÑ ÀÓ»ó Áö½ÄÀÇ ¿ä¾à°ú ÃÖ±Ù º¸°íµÇ°í ÀÖ´Â Ä¡·áÁöħ(guideline)À» ÷ºÎÇÏ¿´´Ù.
µÑ°, È޴뼺ÀÌ ÁÁÀº Å©±â·Î Á¦ÀÛÇÏ¿© ÈÞ´ë°¡ °£ÆíÇÏ´Ù.
¼Â°, ±³°ú¼­¿¡¼­´Â ½±°Ô ã¾ÆÁöÁö ¾ÊÀ¸³ª ÁÖÄ¡ÀÇ°¡ ȯÀÚ¸¦ Áø·áÇÒ ¶§ ¾Ë°í ÀÖ¾î¾ß ÇÏ´Â ³»¿ëÀÌ Ç³¼ºÇÏ°Ô ´ã°Ü ÀÖ´Ù.
ȯÀÚ¸¦ óÀ½ Á¢ÇÏ°Ô µÇ´Â ÀÇ°ú´ëÇÐ Çлý, Áø·á Àϼ±¿¡¼­ Áø·á¸¦ ¹è¿ì°í ¼öÇàÇÏ´Â Àü°øÀÇ, ¶ÇÇÑ ½ÇÁ¦ óġ¸¦ ´ã´çÇÏ´Â Áø·áÇöÀåÀÇ ¸ðµç ºÐµé²² ÀÌ Áöħ¼­°¡ Å« µµ¿òÀÌ µÇ¸®¶ó È®½ÅÇÑ´Ù.

¸ñÂ÷

01 Gastroenterology
¥°. Upper GI disease
1. Esophageal motility disorder
2. GERD (Gastroesophageal reflux disease)
3. Various esophagitis
4. Gastropathy and gastritis
5. Helicobacter pylori
6. Peptic ulcer disease (PUD)
7. NSAID induced gastrointestinal damage
8. Gastric polyps
9. À§¼±Á¾°ú Á¶±âÀ§¾ÏÀÇ ³»½Ã°æ Ä¡·á
10. Gastrointestinal bleeding

¥±. Lower GI disease
1. ConstipationÀÇ Áø´Ü°ú Ä¡·á
2. Diarrhea
3. Ischemic diseases of the bowel
4. Infectious gastroenteritis
5. Inflammatory bowel diseases
6. Intestinal tuberculosis (´ëÇѼÒÈ­±âÇÐȸ °¡À̵å¶óÀÎ Âü°í)
7. Colonic diverticula
8. Intestinal obstruction
9. Colon polyp (´ëÀå ¿ëÁ¾)
10. Functional Dyspepsia
11. Irritable Bowel Syndrome

02 Hepatobiliary disease
1. Liver function testÀÇ Çؼ®
2. Acute hepatitis A
3. Chronic Hepatitis B
4. Chronic Hepatitis C
5. Autoimmune hepatitis
6. Alcoholic hepatitis
7. Ischemic hepatitis (shock liver)
8. Liver abscess (pyogenic, amebic)
9. Acute hepatitis/acute hepatic failure
10. Drug induced liver injury
11. Cirrhosis
12. Gastroesophageal Varices & Variceal Hemorrhage
13. Ascites
14. Spontaneous bacterial peritonitis (SBP)
15. Hepatic encephalopathy
16. Hepatorenal syndrome
17. HCC (hepatocellular carcinoma)
18. Biliary Tract Disease
19. Pancreatitis
20. EUS (Endoscopic ultrasonography)
21. Tumor in pancreas

03 Cardiology
1. Ischemic heart disease
2. Heart Failure
3. ½É±ÙÁúȯ
4. Valvular Heart Disease
4-1. Mitral Stenosis (MS)
4-2. Mitral Regurgitation (MR)
4-3. Aortic Stenosis (AS)
4-4. Aortic Regurgitation (AR)
4-5. Preop. evaluation pathway for VHD in SMC
4-6. ÆǸ·Áúȯ ȯÀÚ¿¡¼­ÀÇ Ç×ÀÀ°í ¿ä¹ý
5. ½É³¶Áúȯ
6. Arrhythmia
7. Syncope
8. Hypertension
9. Aorta Disease
10. Peripheral artery diseases (PAD)
10-1. Ischemic limb disease
10-2. Extracranial Carotid Stenosis
11. Ç÷°ü¿°(Vasculitis)
11-1. Ÿī¾ß¼ö µ¿¸Æ¿°(Takayasu¡¯s arteritis)
11-2. ¹ö°Å¾¾ º´(Buerger¡¯s disease, TAO; thromboangiitis obliterans)
12. Pulmonary Hypertension (ESC guideline 2015)
13. Perioperative Cardiovascular Evaluation in Noncardiac Surgery
14. BLS (Basic life support) and ACLS (Advanced cardiac life support)

04 Pulmonology
1. È£Èí±â Áõ»óº° Á¢±Ù¹ý
2. È£Èí±â ³»°úÀÇ °Ë»ç ¹æ¹ýµé
3. Pneumonia (Æó·Å)
4. Lung abscess
5. Mycobacterial disease
6. Bronchiectasis
7. Chronic Obstructive Pulmonary Disease (¸¸¼ºÆó¼â¼º ÆóÁúȯ)
8. Interstitial Lung Disease (°£Áú¼º ÆóÁúȯ)
9. Diffuse panbronchiolitis
10. Pulmonary embolism
11. Pleural effusion
12. ±Þ¼ºÈ£ÈíºÎÀü(Acute respiratory failure)
13. ±â°èȯ±âÀÇ ±âÃÊ
14. ARDS ventilator strategies
14-1. Weaning from Mechanical Ventilation
15. Airway Management
16. Management of shock
17. Sepsis

05 Endocrinology
1. DM (Diabetes Mellitus)
2. ³úÇϼöü Áúȯ
3. °©»ó¼± Áúȯ
4. Disorders of adrenal cortex
5. Pheochromocytoma
6. Osteoporosis
7. Disorders of lipoprotein metabolism (Dyslipidemias)

06 Nephrology
1. ¿ä°Ë»çÀÇ Çؼ®
2. Urine sediment
3. GFR
4. ´Ü¹é´¢(proteinuria)
5. Ç÷´¢È¯ÀÚ
6. ½Å»ý°Ë(Renal biopsy)
7. Renal imaging
8. »ê¿°±â Àå¾Ö
9. Sodium and Water Homeostasis
10. Hyponatremia
11. Hypernatremia
12. Diabetes insipidus
13. Potassium and calcium homeostasis
14. Phosphate and magnesium
15. Acute Kidney Injury
16. Contrast nephropathy
17. Chronic kidney disease
18. CAPD exit site and tunnel infections (ISPD guidelines 2010)
19. CAPD peritonitis
20. Vascular access for hemodialysis
21. Åõ¼® ÀûÀýµµ(Dialysis adequacy)ÀÇ Æò°¡
22. Ç÷¾× Åõ¼® ÇÕº´Áõ(Complication during dialysis)
23. ÀÌ´¢Á¦¿Í refractory edema
24. Primary glomerulonephritis
25. Àü½Å Áúȯ°ú ½ÅÀåÁúȯ

07 Hematology-Oncology
¥°. Hematology
1. Thrombocytopenia
2. Immune thrombocytopenic purpura (ITP)
3. TTP (Thrombotic thrombocytopenic purpura)
4. HUS (Hemolytic uremic syndrome)
5. DIC (Disseminated intravascular coagulation)
6. Approach to the adult patient with anemia
7. Iron deficiency anemia (IDA)
8. Anemia of chronic disease (ACD)
9. Megaloblastic anemia
10. Hemolytic anemia
11. Approach to the adult patients with pancytopenia
12. Aplastic Anemia
13. Myelodysplastic syndrome (MDS)
14. Polycythemia vera (PV)
15. Primary myelofibrosis (PMF)
16. Essential thrombocytosis (ET)
17. Chronic Myeloid Leukemia (CML)
18. Granulocyte-colony stimulating factor (G-CSF) and Erythropoietin
19. Transfusion medicine
20. Introduction of Acute leukemia
21. Acute Myelocytic Leukemia (AML)
22. Acute Lymphoid Leukemia (ALL)
23. Hematopoietic stem cell transplantation (HSCT)
24. Multiple Myeloma (MM)
25. Palpable lymph nodes
26. Non-Hodgkin¡¯s lymphoma (NHL)
27. Hodgkin¡¯s Disease

¥±. Oncology
1. Oncology overview
2. Chemotherapy overview
3. Pain control
4. Antiemesis
5. Oncologic Emergencies
6. Head and neck cancer
7. Esophageal cancer
8. Breast cancer
9. Lung Cancer
10. Stomach cancer
11. ¿ÏÈ­ÀÇÇÐ

08 Infection
1. ¹ß¿­ ȯÀÚ¿¡ ´ëÇÑ ÀÓ»óÀû Á¢±Ù
2. ¼¼±Õ ¹è¾ç °Ë»ç ¹× °¨¼ö¼º Çؼ®
3. ÇǺΠ¿¬Á¶Á÷ °¨¿°
4. °ñ°üÀý °¨¿°
5. ¿ä·Î °¨¿°Áõ(Urinary tract infection, UTI)
6. º¹°­³» °¨¿°(Intraabdominal infection)
7. °¨¿°¼º ½É³»¸·¿°(infective endocarditis)
8. Ä«Å×ÅÍ °ü·Ã Ç÷·ù°¨¿°(catheter-related bloodstream infection)
9. ±Þ¼º ³ú¼ö¸·¿°(Acute meningitis)
10. ¹ÙÀÌ·¯½º °¨¿°Áõ
11. Àμö°øÅë°¨¿°Áõ
12. Áø±Õ °¨¿°Áõ
13. Neutropenic fever
14. ¸»¶ó¸®¾Æ °¨¿°Áõ(Malaria)
15. ¼ºÀÎ ¿¹¹æ Á¢Á¾°ú ¿©Çà ÀÇÇÐ(2019³â ´ëÇÑ°¨¿°ÇÐȸ ±ÇÀå ¼ºÀο¹¹æÁ¢Á¾Ç¥)
16. Àå±â ÀÌ½Ä È¯ÀÚÀÇ °¨¿°Áõ(Post-transplant infection)

09 Rheumatology
1. Approach to articular and musculoskeletal disorders
2. ·ù¸¶Æ¼½º ÁúȯÀ» À§ÇÑ ÀÓ»óº´¸® °Ë»çÀÇ Çؼ®
3. ·ù¸¶Æ¼½º °üÀý¿°(Rheumatoid arthritis)
4. Systemic Lupus Erythematosus(Àü½Å È«¹Ý·çǪ½º)
5. Gout (Monosodium urate gout)
6. Spondyloarthropathies
7. Vasculitis
8. Behcet¡¯s Disease
9. Sj?gren¡¯s syndrome
10. Inflammatory Myopathy(¿°Áõ¼º ±Ùº´Áõ)
11. Scleroderma, Systemic sclerosis
12. Adult Onset Still's Disease (AOSD)
13. ¼¶À¯±ÙÅë(Fibromyalgia)
14. Àç¹ß´Ù¹ß¿¬°ñ¿°(Relapsing polychondritis)

10 Allergy
1. Diagnosis of allergic diseases
2. Asthma
3. Allergic rhinitis
4. Chronic cough
5. Adverse drug reactions
6. Anaphylaxis
7. Eosinophilia(È£»ê±¸Áõ°¡Áõ)
8. Urticaria and angioedema

11 Neurology
1. Neurologic examination
2. Coma
3. Stroke
4. Seizure
5. Spinal cord, spinal nerve, and periphral nerve
6. Headache

°ü·ÃÀ̹ÌÁö

ÀúÀÚ¼Ò°³

»ï¼º¼­¿ïº´¿ø³»°ú [Àú] ½ÅÀ۾˸² SMS½Åû
»ý³â¿ùÀÏ -

ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.

ÀÚ¿¬°ú °úÇÐ ºÐ¾ß¿¡¼­ ¸¹Àº ȸ¿øÀÌ ±¸¸ÅÇÑ Ã¥

    ¸®ºä

    0.0 (ÃÑ 0°Ç)

    100ÀÚÆò

    ÀÛ¼º½Ã À¯ÀÇ»çÇ×

    ÆòÁ¡
    0/100ÀÚ
    µî·ÏÇϱâ

    100ÀÚÆò

    0.0
    (ÃÑ 0°Ç)

    ÆǸÅÀÚÁ¤º¸

    • ÀÎÅÍÆÄÅ©µµ¼­¿¡ µî·ÏµÈ ¿ÀǸ¶ÄÏ »óÇ°Àº ±× ³»¿ë°ú Ã¥ÀÓÀÌ ¸ðµÎ ÆǸÅÀÚ¿¡°Ô ÀÖÀ¸¸ç, ÀÎÅÍÆÄÅ©µµ¼­´Â ÇØ´ç »óÇ°°ú ³»¿ë¿¡ ´ëÇØ Ã¥ÀÓÁöÁö ¾Ê½À´Ï´Ù.

    »óÈ£

    (ÁÖ)±³º¸¹®°í

    ´ëÇ¥ÀÚ¸í

    ¾Èº´Çö

    »ç¾÷ÀÚµî·Ï¹øÈ£

    102-81-11670

    ¿¬¶ôó

    1544-1900

    ÀüÀÚ¿ìÆíÁÖ¼Ò

    callcenter@kyobobook.co.kr

    Åë½ÅÆǸž÷½Å°í¹øÈ£

    01-0653

    ¿µ¾÷¼ÒÀçÁö

    ¼­¿ïƯº°½Ã Á¾·Î±¸ Á¾·Î 1(Á¾·Î1°¡,±³º¸ºôµù)

    ±³È¯/ȯºÒ

    ¹ÝÇ°/±³È¯ ¹æ¹ý

    ¡®¸¶ÀÌÆäÀÌÁö > Ãë¼Ò/¹ÝÇ°/±³È¯/ȯºÒ¡¯ ¿¡¼­ ½Åû ¶Ç´Â 1:1 ¹®ÀÇ °Ô½ÃÆÇ ¹× °í°´¼¾ÅÍ(1577-2555)¿¡¼­ ½Åû °¡´É

    ¹ÝÇ°/±³È¯°¡´É ±â°£

    º¯½É ¹ÝÇ°ÀÇ °æ¿ì Ãâ°í¿Ï·á ÈÄ 6ÀÏ(¿µ¾÷ÀÏ ±âÁØ) À̳»±îÁö¸¸ °¡´É
    ´Ü, »óÇ°ÀÇ °áÇÔ ¹× °è¾à³»¿ë°ú ´Ù¸¦ °æ¿ì ¹®Á¦Á¡ ¹ß°ß ÈÄ 30ÀÏ À̳»

    ¹ÝÇ°/±³È¯ ºñ¿ë

    º¯½É ȤÀº ±¸¸ÅÂø¿À·Î ÀÎÇÑ ¹ÝÇ°/±³È¯Àº ¹Ý¼Û·á °í°´ ºÎ´ã
    »óÇ°À̳ª ¼­ºñ½º ÀÚüÀÇ ÇÏÀÚ·Î ÀÎÇÑ ±³È¯/¹ÝÇ°Àº ¹Ý¼Û·á ÆǸÅÀÚ ºÎ´ã

    ¹ÝÇ°/±³È¯ ºÒ°¡ »çÀ¯

    ·¼ÒºñÀÚÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óÇ° µîÀÌ ¼Õ½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì
    (´ÜÁö È®ÀÎÀ» À§ÇÑ Æ÷Àå ÈѼÕÀº Á¦¿Ü)

    ·¼ÒºñÀÚÀÇ »ç¿ë, Æ÷Àå °³ºÀ¿¡ ÀÇÇØ »óÇ° µîÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì
    ¿¹) È­ÀåÇ°, ½ÄÇ°, °¡ÀüÁ¦Ç°(¾Ç¼¼¼­¸® Æ÷ÇÔ) µî

    ·º¹Á¦°¡ °¡´ÉÇÑ »óÇ° µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì
    ¿¹) À½¹Ý/DVD/ºñµð¿À, ¼ÒÇÁÆ®¿þ¾î, ¸¸È­Ã¥, ÀâÁö, ¿µ»ó È­º¸Áý

    ·½Ã°£ÀÇ °æ°ú¿¡ ÀÇÇØ ÀçÆǸŰ¡ °ï¶õÇÑ Á¤µµ·Î °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì

    ·ÀüÀÚ»ó°Å·¡ µî¿¡¼­ÀÇ ¼ÒºñÀÚº¸È£¿¡ °üÇÑ ¹ý·üÀÌ Á¤ÇÏ´Â ¼ÒºñÀÚ Ã»¾àöȸ Á¦ÇÑ ³»¿ë¿¡ ÇØ´çµÇ´Â °æ¿ì

    »óÇ° Ç°Àý

    °ø±Þ»ç(ÃâÆÇ»ç) Àç°í »çÁ¤¿¡ ÀÇÇØ Ç°Àý/Áö¿¬µÉ ¼ö ÀÖÀ½

    ¼ÒºñÀÚ ÇÇÇغ¸»ó
    ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó

    ·»óÇ°ÀÇ ºÒ·®¿¡ ÀÇÇÑ ±³È¯, A/S, ȯºÒ, Ç°Áúº¸Áõ ¹× ÇÇÇغ¸»ó µî¿¡ °üÇÑ »çÇ×Àº ¼ÒºñÀÚºÐÀïÇØ°á ±âÁØ (°øÁ¤°Å·¡À§¿øȸ °í½Ã)¿¡ ÁØÇÏ¿© 󸮵Ê

    ·´ë±Ý ȯºÒ ¹× ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó±Ý Áö±Þ Á¶°Ç, ÀýÂ÷ µîÀº ÀüÀÚ»ó°Å·¡ µî¿¡¼­ÀÇ ¼ÒºñÀÚ º¸È£¿¡ °üÇÑ ¹ý·ü¿¡ µû¶ó ó¸®ÇÔ

    (ÁÖ)KGÀ̴Ͻýº ±¸¸Å¾ÈÀü¼­ºñ½º¼­ºñ½º °¡ÀÔ»ç½Ç È®ÀÎ

    (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º´Â ȸ¿ø´ÔµéÀÇ ¾ÈÀü°Å·¡¸¦ À§ÇØ ±¸¸Å±Ý¾×, °áÁ¦¼ö´Ü¿¡ »ó°ü¾øÀÌ (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º¸¦ ÅëÇÑ ¸ðµç °Å·¡¿¡ ´ëÇÏ¿©
    (ÁÖ)KGÀ̴Ͻýº°¡ Á¦°øÇÏ´Â ±¸¸Å¾ÈÀü¼­ºñ½º¸¦ Àû¿ëÇÏ°í ÀÖ½À´Ï´Ù.

    ¹è¼Û¾È³»

    • ±³º¸¹®°í »óÇ°Àº Åùè·Î ¹è¼ÛµÇ¸ç, Ãâ°í¿Ï·á 1~2Àϳ» »óÇ°À» ¹Þ¾Æ º¸½Ç ¼ö ÀÖ½À´Ï´Ù.

    • Ãâ°í°¡´É ½Ã°£ÀÌ ¼­·Î ´Ù¸¥ »óÇ°À» ÇÔ²² ÁÖ¹®ÇÒ °æ¿ì Ãâ°í°¡´É ½Ã°£ÀÌ °¡Àå ±ä »óÇ°À» ±âÁØÀ¸·Î ¹è¼ÛµË´Ï´Ù.

    • ±ººÎ´ë, ±³µµ¼Ò µî ƯÁ¤±â°üÀº ¿ìü±¹ Åù踸 ¹è¼Û°¡´ÉÇÕ´Ï´Ù.

    • ¹è¼Ûºñ´Â ¾÷ü ¹è¼Ûºñ Á¤Ã¥¿¡ µû¸¨´Ï´Ù.

    • - µµ¼­ ±¸¸Å ½Ã 15,000¿ø ÀÌ»ó ¹«·á¹è¼Û, 15,000¿ø ¹Ì¸¸ 2,500¿ø - »óÇ°º° ¹è¼Ûºñ°¡ ÀÖ´Â °æ¿ì, »óÇ°º° ¹è¼Ûºñ Á¤Ã¥ Àû¿ë